Gotham Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.2M | Buy |
80,477
+20,739
| +35% | +$13.3M | 0.14% | 144 |
|
|
2025
Q4 | $40.4M | Buy |
59,738
+11,095
| +23% | +$7.56M | 0.15% | 114 |
|
|
2025
Q3 | $31.1M | Buy |
48,643
+13,986
| +40% | +$8.49M | 0.14% | 153 |
|
|
2025
Q2 | $18.6M | Buy |
34,657
+14,208
| +69% | +$6.79M | 0.11% | 225 |
|
|
2025
Q1 | $8.59M | Buy |
20,449
+6,687
| +49% | +$2.9M | 0.07% | 387 |
|
|
2024
Q4 | $5.69M | Sell |
13,762
-5,600
| -29% | -$2.46M | 0.05% | 483 |
|
|
2024
Q3 | $9.78M | Buy |
19,362
+3,702
| +24% | +$1.8M | 0.1% | 290 |
|
|
2024
Q2 | $7.63M | Sell |
15,660
-2,882
| -16% | -$1.45M | 0.1% | 286 |
|
|
2024
Q1 | $10M | Buy |
18,542
+9,914
| +115% | +$5.42M | 0.15% | 140 |
|
|
2023
Q4 | $4.79M | Sell |
8,628
-8,799
| -50% | -$4.13M | 0.09% | 307 |
|
|
2023
Q3 | $7.62M | Buy |
17,427
+7,741
| +80% | +$3.86M | 0.16% | 127 |
|
|
2023
Q2 | $4.86M | Sell |
9,686
-1,188
| -11% | -$569K | 0.11% | 245 |
|
|
2023
Q1 | $5.44M | Sell |
10,874
-663
| -6% | -$317K | 0.13% | 169 |
|
|
2022
Q4 | $4.71M | Sell |
11,537
-1,324
| -10% | -$514K | 0.13% | 177 |
|
|
2022
Q3 | $4.19M | Buy |
12,861
+51
| +0.4% | +$18.7K | 0.13% | 191 |
|
|
2022
Q2 | $4.49M | Buy |
12,810
+8,926
| +230% | +$3.64M | 0.14% | 171 |
|
|
2022
Q1 | $2.13M | Buy |
3,884
+1,807
| +87% | +$951K | 0.07% | 336 |
|
|
2021
Q4 | $1.37M | Sell |
2,077
-4,338
| -68% | -$2.72M | 0.04% | 460 |
|
|
2021
Q3 | $3.99M | Buy |
6,415
+772
| +14% | +$519K | 0.16% | 182 |
|
|
2021
Q2 | $3.56M | Sell |
5,643
-489
| -8% | -$270K | 0.15% | 199 |
|
|
2021
Q1 | $3M | Sell |
6,132
-44
| -0.7% | -$22K | 0.13% | 224 |
|
|
2020
Q4 | $3.09M | Sell |
6,176
-485
| -7% | -$217K | 0.1% | 262 |
|
|
2020
Q3 | $2.62M | Buy |
+6,661
| New | +$2.46M | 0.08% | 310 |
|
|
2020
Q1 | – | Sell |
-7,865
| Closed | -$2.05M | – | 1135 |
|
|
2019
Q4 | $2.05M | Buy |
+7,865
| New | +$2.07M | 0.04% | 464 |
|
|
2019
Q1 | – | Sell |
-5,413
| Closed | -$1.01M | – | 1200 |
|
|
2018
Q4 | $1.01M | Buy |
+5,413
| New | +$1.11M | 0.02% | 630 |
|
|
2018
Q1 | – | Sell |
-4,620
| Closed | -$722K | – | 1001 |
|
|
2017
Q4 | $722K | Buy |
4,620
+2,411
| +109% | +$380K | 0.01% | 648 |
|
|
2017
Q3 | $343K | Buy |
+2,209
| New | +$349K | 0.01% | 774 |
|
|
2014
Q4 | – | Sell |
-310,646
| Closed | -$18.3M | – | 992 |
|
|
2014
Q3 | $18.3M | Buy |
+310,646
| New | +$19.6M | 0.18% | 198 |
|
|
2014
Q2 | – | Sell |
-5,636
| Closed | -$342K | – | 1040 |
|
|
2014
Q1 | $342K | Sell |
5,636
-32
| -0.6% | -$1.91K | 0.01% | 868 |
|
|
2013
Q4 | $301K | Sell |
5,668
-238
| -4% | -$12.5K | 0.01% | 865 |
|
|
2013
Q3 | $294K | Sell |
5,906
-1,768
| -23% | -$85K | 0.01% | 791 |
|
|
2013
Q2 | $344K | Buy |
+7,674
| New | +$335K | 0.01% | 743 |
|
Other funds holding IDXX
VCM
VPM
Gotham Asset Management's IDXX Position: Q1 2026 in Review
Gotham Asset Management increased its Idexx Laboratories (IDXX) stake by 35% in Q1 2026, buying an estimated $13.3M and bringing the position to 80,477 shares worth $45.2M. The position accounts for 0.14% of the portfolio, ranked #144.
Gotham Asset Management first reported a position in IDXX in Q2 2013 and has held it in 32 quarters since. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Gotham Asset Management held 80,477 shares of Idexx Laboratories worth $45.2M as of Q1 2026.
- Gotham Asset Management bought 20,739 Idexx Laboratories shares in Q1 2026, an estimated $13.3M.
- Idexx Laboratories made up 0.14% of Gotham Asset Management's portfolio in Q1 2026, its #144 holding.
- Gotham Asset Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 32 quarters since.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.